Ledger.Open graph →
SEC Form D · filed June 10, 2020

Octagon Therapeutics, Inc

Offering
$1.0M
Sold
$398K
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
CAMBRIDGE, MA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (4)

Isaac Stoner · Cambridge, MAExec · DirectorFred Ausubel · Cambridge, MAExec · DirectorIsaac Stoner · Cambridge, MAExec · DirectorFred Ausubel · Cambridge, MAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗